These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17346208)

  • 21. VirB8: a conserved type IV secretion system assembly factor and drug target.
    Baron C
    Biochem Cell Biol; 2006 Dec; 84(6):890-9. PubMed ID: 17215876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms].
    Sundin C; Elofsson M; Wolf-Watz H; Rosell S
    Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2543-5. PubMed ID: 19908625
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.
    Duncan MC; Linington RG; Auerbuch V
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5433-41. PubMed ID: 22850518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story.
    Stathopoulos C; Hendrixson DR; Thanassi DG; Hultgren SJ; St Geme JW; Curtiss R
    Microbes Infect; 2000 Jul; 2(9):1061-72. PubMed ID: 10967286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell Envelope.
    Graef F; Gordon S; Lehr CM
    Curr Top Microbiol Immunol; 2016; 398():475-496. PubMed ID: 26942419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic transglycosylases in macromolecular transport systems of Gram-negative bacteria.
    Koraimann G
    Cell Mol Life Sci; 2003 Nov; 60(11):2371-88. PubMed ID: 14625683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivering the payload. Bacterial pathogenesis.
    Stephens C; Shapiro L
    Curr Biol; 1996 Aug; 6(8):927-30. PubMed ID: 8805313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New structural insights into the bacterial type III secretion system.
    Yip CK; Strynadka NC
    Trends Biochem Sci; 2006 Apr; 31(4):223-30. PubMed ID: 16537106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial secrets of secretion: EuroConference on the biology of type IV secretion processes.
    Baron C; OCallaghan D; Lanka E
    Mol Microbiol; 2002 Mar; 43(5):1359-65. PubMed ID: 11918819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type IV secretion systems in pathogenic bacteria.
    Fischer W; Haas R; Odenbreit S
    Int J Med Microbiol; 2002 Sep; 292(3-4):159-68. PubMed ID: 12398207
    [No Abstract]   [Full Text] [Related]  

  • 32. Type IV Pili as a Therapeutic Target.
    Duménil G
    Trends Microbiol; 2019 Aug; 27(8):658-661. PubMed ID: 31182345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type II secretion: a protein secretion system for all seasons.
    Cianciotto NP
    Trends Microbiol; 2005 Dec; 13(12):581-8. PubMed ID: 16216510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific chemical modification of bacterial type I dehydroquinase--opportunities for drug discovery.
    González-Bello C
    Future Med Chem; 2015; 7(17):2371-83. PubMed ID: 26599605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Galán JE; Collmer A
    Science; 1999 May; 284(5418):1322-8. PubMed ID: 10334981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y; Eguchi Y; Watanabe T; Okamoto S; Doi A; Utsumi R
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the Targets of Type III Secretion System Inhibitors.
    Condry DL; Nilles ML
    Methods Mol Biol; 2017; 1531():203-211. PubMed ID: 27837494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion systems in Gram-negative bacteria: structural and mechanistic insights.
    Costa TR; Felisberto-Rodrigues C; Meir A; Prevost MS; Redzej A; Trokter M; Waksman G
    Nat Rev Microbiol; 2015 Jun; 13(6):343-59. PubMed ID: 25978706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial thiol oxidoreductases - from basic research to new antibacterial strategies.
    Bocian-Ostrzycka KM; Grzeszczuk MJ; Banaś AM; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2017 May; 101(10):3977-3989. PubMed ID: 28409380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.